IO Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 11/13/2024 | 6.17 M | $6.48 M | 0.00% | 9.37% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 3.64 M | $3.82 M | 0.00% | 5.53% |
| NOVO HOLDINGS A/S | 10/24/2024 | 3.35 M | $3.52 M | -24.27% | 5.09% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 2.34 M | $2.46 M | 0.00% | 3.55% |
| MORGAN STANLEY | 11/14/2024 | 2.20 M | $2.31 M | 11.65% | 3.34% |
| MARSHALL WACE, LLP | 11/14/2024 | 2.11 M | $2.21 M | 0.00% | 3.20% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1.65 M | $1.73 M | 0.00% | 2.51% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2024 | 864,197 | $907,407 | 0.00% | 1.31% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 493,827 | $518,518 | 0.00% | 0.75% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 199,623 | $209,604 | 60.18% | 0.30% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 192,670 | $202,304 | 0.00% | 0.29% |
| UBS GROUP AG | 11/14/2024 | 107,906 | $113,301 | 3,189.82% | 0.16% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 97,000 | $101,850 | -46.35% | 0.15% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 60,650 | $63,000 | 100.00% | 0.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 33,307 | $34,972 | 0.00% | 0.05% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 30,000 | $31,500 | 100.00% | 0.05% |
| HRT FINANCIAL LP | 11/12/2024 | 26,646 | $27,000 | 100.00% | 0.04% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 17,954 | $19,000 | 100.00% | 0.03% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 230 | $242 | 100.00% | 0.00% |
| FMR LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
IO Biotech, Inc.institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of IO Biotech, Inc.. The most heavily invested institutionals were:
Vivo Capital, LLC: 6.17 M
Samsara BioCapital, LLC: 3.64 M
Novo Holdings A/S: 3.35 M
PFM Health Sciences, LP: 2.34 M
MORGAN STANLEY: 2.2 M
MARSHALL WACE, LLP: 2.11 M
35.81% of IO Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 23.59 M shares in the last 24 months. This purchase volume represents approximately $19.35 M in transactions.